Atlas Trials

ALK-negative Anaplastic Large Cell Lymphoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ALK-negative Anaplastic Large Cell Lymphoma

RecordFirmDate
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms (NCT03493451)BeiGene2018-04-13
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma (NCT01746992)Ruijin Hospital2012-09-01

Track ALK-negative Anaplastic Large Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.